Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	89.32	54.88	97.99	66.62	63.34
Short-Term Investments	183.46	355.95	290.61	219.36	37.93
Cash & Cash Equivalents	272.79	410.82	388.6	285.98	101.27
Cash Growth	-33.60%	5.72%	35.88%	182.41%	98.79%
Receivables	25.81	8.46	0	0	0
Inventory	13.13	7.51	0	0	0
Other Current Assets	18.7	10.61	14.17	6.84	5.21
Total Current Assets	330.43	437.41	402.77	292.83	106.47
Property, Plant & Equipment	3.9	4.6	5.3	5.37	0.49
Goodwill and Intangibles	6.44	7.19	0	0	0
Other Long-Term Assets	0.6	0.08	0.08	0.08	0.05
Total Long-Term Assets	10.93	11.87	5.38	5.44	0.54
Total Assets	341.37	449.27	408.15	298.27	107.01
Accounts Payable	11.99	8.83	7.35	7.14	1.41
Current Debt	0.74	0.66	0.43	0	0.18
Other Current Liabilities	33.94	28.32	25.54	15.46	3.65
Total Current Liabilities	46.67	37.81	33.33	22.6	5.24
Long-Term Debt	205.18	201.89	77.12	4.96	0.13
Other Long-Term Liabilities	0.85	0	0.03	0.08	0.18
Total Long-Term Liabilities	206.03	201.89	77.15	5.05	0.31
Total Liabilities	252.7	239.69	110.48	27.65	5.55
Total Debt	205.92	202.54	77.56	4.96	0.31
Debt Growth	1.67%	161.15%	1462.39%	1516.94%	-
Retained Earnings	-981.9	-719.76	-408.31	-201.95	-66.27
Comprehensive Income	0	-1.09	-0.26	-0	-0
Shareholders' Equity	88.67	209.58	297.68	270.62	-65.03
Net Cash / Debt	66.87	208.28	311.04	281.02	100.96
Net Cash / Debt Growth	-67.89%	-33.04%	10.68%	178.35%	98.19%
Net Cash Per Share	0.96	3.78	6.30	7.88	54.77
Working Capital	283.76	399.6	369.45	270.22	101.24
Book Value Per Share	1.28	3.81	6.03	7.59	-35.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).